Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate (BIODYMF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02883439
Recruitment Status : Withdrawn (no available patients)
First Posted : August 30, 2016
Last Update Posted : July 13, 2021
MEDA Pharma GmbH & Co. KG
University of Wuerzburg
Information provided by (Responsible Party):
University Hospital, Ghent

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : March 2020
Actual Study Completion Date : March 2020